Silence Therapeutics plc
SLNCF
$1.69
$0.0855.31%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.70M | -73.10M | -46.88M | -74.69M | -49.99M |
| Total Depreciation and Amortization | 585.50K | 587.50K | 601.50K | 592.50K | 601.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.94M | 6.28M | 4.03M | 20.10M | 10.79M |
| Change in Net Operating Assets | -20.13M | -4.69M | -25.51M | -583.70K | 3.43M |
| Cash from Operations | -87.29M | -70.92M | -67.75M | -54.58M | -35.17M |
| Capital Expenditure | -181.60K | -218.60K | -214.60K | -148.80K | -110.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.97M | -19.42M | -24.95M | -88.48M | -24.87M |
| Cash from Investing | -21.15M | -19.64M | -25.16M | -88.63M | -24.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 133.80K | 133.80K | 133.80K | 117.90K | 117.90K |
| Issuance of Common Stock | 6.35M | 7.55M | 140.55M | 152.06M | 158.47M |
| Repurchase of Common Stock | -7.38M | -7.38M | -7.38M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.28M | 8.28M | 8.28M | 539.10K | 185.10K |
| Cash from Financing | 9.18M | 10.37M | 143.38M | 154.51M | 161.98M |
| Foreign Exchange rate Adjustments | 452.10K | 240.10K | -26.90K | -6.06M | 2.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.82M | -79.94M | 50.43M | 5.24M | 103.92M |